染色恐惧性细胞癌中脱差和攻击性的分子基础
Payal Kapur1,2,3, Hua Zhong1,4, Daniel Le5
1Department of Pathology and.
JCI insight
|May 22, 2024
概括
染色恐惧性细胞癌 (ChRCC) 脱差涉及TP53和PTEN突变,导致攻击性的亚型. 这种进展的标志是基因表达变化和全基因组重复,提供新的诊断生物标志物.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 病理学 病理学 病理学
背景情况:
- 瘤细胞脱差是细胞癌 (RCC) 亚型中常见的,具有攻击性的特征,包括染色恐惧型RCC (ChRCC).
- 无差异化的RCC对向治疗具有耐药性,但对免疫疗法具有高度敏感性.
- 了解CHRCC的脱差对于改善治疗策略和患者的治疗结果至关重要.
研究的目的:
- 为了研究导致ChRCC脱差的病理和基因组机制.
- 识别CHRCC进展中的分子驱动因素和中间状态.
- 探索攻击性CHRCC亚型的潜在生物标志物.
主要方法:
- 多区域综合病理和基因组分析ChRCC.
- 差异化和非差异化CHRCC亚型的比较分析.
- 研究基因表达,突变 (TP53,PTEN) 和染色体变化 (全基因组复制).
主要成果:
- 慢性RCC分化为 Sarcomatoid,Anaplastic和腺体亚型,所有这些都与增加的攻击性和转移有关.
- 脱差涉及表皮标记物的丧失,融合基因表达,以及从低二倍体状态的全基因组重复.
- TP53和PTEN突变启动脱差,成为染色体重复 (17和10染色体) 的同卵性.
- mTORC1的激活和p53的稳定作为脱差区域的潜在生物标志物.
结论:
- 在CHRCC中脱差是一种复杂的过程,由特定的遗传突变和染色体改变驱动.
- 在非分化的CHRCC中观察到融合的进化轨迹,类似于其他肉 Sarcomatoid RCC.
- 这项研究增强了对攻击性CHRCC的理解,为分类提供了信息,并有助于诊断.
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.6K
08:11Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
8.3K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
